These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1119822)

  • 41. Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid.
    Guevara IL; Pandya AG
    Int J Dermatol; 2001 Mar; 40(3):212-5. PubMed ID: 11422530
    [No Abstract]   [Full Text] [Related]  

  • 42. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
    Dadzie OE; Petit A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of hyperpigmentation.
    Rossi AM; Perez MI
    Facial Plast Surg Clin North Am; 2011 May; 19(2):313-24. PubMed ID: 21763992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Advances in topical therapy of skin diseases (author's transl)].
    Happle R
    MMW Munch Med Wochenschr; 1979 Jan; 121(4):141-4. PubMed ID: 153470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapy of melanin-induced pigment anomalies].
    Herzberg JJ
    Hautarzt; 1985 Nov; 36(11):635-8. PubMed ID: 3908403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experience in the treatment of hyperpigmentation of facial skin with hydroquinone monobenzyl ether].
    Gusarova AS; Zalem ZIa
    Vestn Dermatol Venerol; 1966 Mar; 40(3):49-52. PubMed ID: 5988245
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of hyperpigmentations of the skin with hydroguinone (depigmentation ointment)].
    Peisert E; Król C
    Przegl Dermatol; 1972; 59(2):205-9. PubMed ID: 5023356
    [No Abstract]   [Full Text] [Related]  

  • 49. Melasma--updated treatments.
    Situm M; Kolić M; Bolanca Z; Ljubicić I; Misanović B
    Coll Antropol; 2011 Sep; 35 Suppl 2():315-8. PubMed ID: 22220462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison between Intralesional Triamcinolone and Kligman's Formula in Treatment of Melasma.
    Eshghi G; Khezrian L; Esna Ashari F
    Acta Med Iran; 2016 Jan; 54(1):67-71. PubMed ID: 26853293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperpigmentation: an overview of the common afflictions.
    Cayce KA; McMichael AJ; Feldman SR
    Dermatol Nurs; 2004 Oct; 16(5):401-6, 413-6; quiz 417. PubMed ID: 15624705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of nonhairy melanocytic macules by dermabrasion and topical application of 5% hydroquinone monobenzyl ether cream.
    Tezuka T; Saheki M; Kusuda S; Umemoto K
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):771-2. PubMed ID: 8496423
    [No Abstract]   [Full Text] [Related]  

  • 56. Retinoid therapy of pigmentary disorders.
    Ortonne JP
    Dermatol Ther; 2006; 19(5):280-8. PubMed ID: 17014483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complementary effects of topical antiaging treatments in conjunction with aesthetic procedures.
    Bruce S
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s23-7. PubMed ID: 18404868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of light-induced hyperpigmentation of the skin with hydroquinone monobenzyl ester].
    Lur'e VG; Lur'e IV
    Vestn Dermatol Venerol; 1968 Feb; 42(2):84-6. PubMed ID: 5741236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.